Announcement of resolution of the seventh meeting of the third session of the Board of Supervisors

release time:

2024-04-23 16:23

AnnouncementNumber: 2023-018

Stock code: 832316               Securities abbreviation: Tian Zheng Biotech                  Host brokerage: Shenwan Hongyuan underwriting sponsor


Jilin Tianzheng Biotechnology Co., Ltd

Announcement of resolution of the seventh meeting of the third session of the Board of Supervisors


The Company and all members of the Board of Directors warrant that the content of the announcement is true, accurate and complete, and there are no false records, misleading statements or material omissions, and assume individual and joint legal responsibility for the authenticity, accuracy and completeness of its content.


1. The convening and attendance of the meeting
(1) Information on the convening of the meeting
1. Meeting Date: August 18, 2023
2. Meeting place: Conference room on the third floor of the company
3. Meeting mode: to be held on site
4. The time and method of sending the notice of the meeting of the Supervisory Board: by written notice on  August 8, 2023
5. Moderator: Shi Chunyan, Chairman of the Board of Supervisors

6. Legal and Compliance description of the meeting:

The convening and convening of this meeting are in accordance with the relevant provisions of the Company Law and relevant laws, administrative regulations and the Articles of Association. 

(2) Attendance at the meeting
 There shall be 3 directors present at the meeting, and 3 directors present and authorized to attend the meeting.


2. Deliberation of bills
(1) Deliberating and adopting the motion on the Company's Semi-Annual Report for 2023
1. Contents of the motion:
In accordance with the Measures for the Supervision and Administration of Non-listed Public Companies and the Information Disclosure Management Office of Non-listed Public Companies
Law ", "National SME Share Transfer System Listed Company Information Disclosure Rules" and "About doing a good job listed public
The Department of 2023 semi-annual report disclosure of relevant work Notice "and other relevant requirements of the company's board of supervisors to the company
The Semi-Annual Report 2023 was reviewed and the following comments were made:
1. The preparation and review procedures of the company's semi-annual report in 2023 comply with laws, regulations, the articles of association and the public
The provisions of the Division's internal management system.
2. The content and format of the company's semi-annual report in 2023 conform to the national SME share transfer system
Limited liability company provisions, no inconsistency was found in the information contained in the company's semi-annual report for 2023
In line with the actual situation, the company's semi-annual report in 2023 truly reflects the company's operating results and financial performance during the period
Business status.
3. Prior to the submission of this opinion, no breach of confidentiality has been found by the personnel involved in the preparation and review of the semi-annual report
Prescribed conduct.

2 Motion vote: Yes by 3 votes; Against : 0; Abstentions 0.
3. Avoidance of votes: None.

4. Submission to Shareholders Meeting for Vote: This motion does not need to be submitted to shareholders meeting for consideration.


3. File directory for reference
Resolution of the Seventh Meeting of the Third Board of Supervisors of Jilin Tianzheng Biotechnology Co., LTD.
Audit of the semi-annual Report of the company in 2023 by the Board of Supervisors of Jilin Tianzheng Biotechnology Co., LTD Opinion


Jilin Tianzheng Biotechnology Co., LTD
Board of supervisors
August 18, 2023